Literature DB >> 19867033

ON THE PHYSIOLOGY OF HEART-BLOCK IN MAMMALS, WITH ESPECIAL REFERENCE TO THE CAUSATION OF STOKES-ADAMS DISEASE.

J Erlanger1.   

Abstract

THE FACTS COLLECTED IN THE THIRD PART OF THIS PAPER JUSTIFY THE FOLLOWING
CONCLUSIONS: (1) All of the cardinal symptoms of Stokes-Adams disease may be duplicated by heart-block resulting from a lesion in or near the auriculo-ventricular bundle of His, and by this alone. (2) No typical case of Stokes-Adams disease has been described in which heart-block might not have been the cause of the trouble. (3) It can be shown that all cases of Stokes-Adams disease which have been studied by sufficiently accurate methods were cases of heart-block. (4) It would appear that heart-block without and with syncopal attacks are two stages of the same disease process.

Entities:  

Year:  1906        PMID: 19867033      PMCID: PMC2124603          DOI: 10.1084/jem.8.1.8

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  6 in total

1.  Acute complete heart block in dogs.

Authors:  T E STARZL; R A GAERTNER; R R BAKER
Journal:  Circulation       Date:  1955-07       Impact factor: 29.690

2.  Chronic heart block in dogs; a method for producing experimental heart failure.

Authors:  T E STARZL; R A GAERTNER
Journal:  Circulation       Date:  1955-08       Impact factor: 29.690

3.  [Morphologic findings in complete heart block].

Authors:  H J Knieriem; S Effert
Journal:  Klin Wochenschr       Date:  1966-04-01

4.  Paroxysmal atrioventricular block: are phase 3 and phase 4 block mechanisms or misnomers?

Authors:  Nabil El-Sherif; José Jalife
Journal:  Heart Rhythm       Date:  2009-06-21       Impact factor: 6.343

5.  Experimental models of complete heart block.

Authors:  E K Weir; I F McMurtry; R F Grover
Journal:  Basic Res Cardiol       Date:  1975 Jul-Aug       Impact factor: 17.165

Review 6.  The canine chronic atrioventricular block model in cardiovascular preclinical drug research.

Authors:  Vera Loen; Marc A Vos; Marcel A G van der Heyden
Journal:  Br J Pharmacol       Date:  2021-05-04       Impact factor: 9.473

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.